Brief: BioArctic And Lilly Sign Research, Collaboration Agreement
22/06/2026 06:35
BRIEF-BioArctic And Lilly Sign Research, Collaboration Agreement June 22 (Reuters) - BioArctic AB BIOAb.ST:
CO AND LILLY SIGN RESEARCH, COLLABORATION AGREEMENT COMBINING LILLY COMPOUND WITH CO'S BRAINTRANSPORTER TECHNOLOGY
TO RECEIVE $30 MILLION UPFRONT PAYMENT FROM LILLY
ELIGIBLE FOR UP TO $770 MILLION IN MILESTONE PAYMENTS
Source text: ID:nWkrbwlfYD
Further company coverage: [BIOAb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln